Novartis AG ADR

Yahoo Finance • 4 days ago

Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets

Novartis Pharma AG Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance rolled forward to +5-6% cc CAGR for 2025-2030, following upgrade of 2024-2029 guidance to +6% cc1 Peak sales guidance upgraded for Kisqali and Scembli... Full story

Yahoo Finance • 4 days ago

Novartis To Build Flagship Manufacturing Hub In North Carolina

(RTTNews) - Novartis (NVS) announced plans to expand its operations in North Carolina with the creation of a new flagship manufacturing hub featuring end-to-end capabilities. This strategic investment marks a significant step toward ensuri... Full story

Yahoo Finance • 4 days ago

Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110

Novartis AG (NYSE:NVS) is included among the 12 Best European Dividend Stocks to Buy Now.Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110 Photo by Dan Dennis on Unsplash O⁠n October 31, Morgan‍ Stanley... Full story

Yahoo Finance • 4 days ago

Malaria Breakthrough Might Change The Case For Investing In Novartis (SWX:NOVN)

Novartis recently announced positive Phase III results from its KALUMA study of GanLum (ganaplacide/lumefantrine), a new malaria treatment targeting growing drug resistance in Africa, with details presented at a major global tropical medic... Full story

Yahoo Finance • 4 days ago

Novartis to establish a manufacturing center in North Carolina

[Heavy Industry Manufacturing Factory: Scientist in Sterile Coverall Walking with Laptop Computer, Examining Industrial CNC Machine Settings and Configuring Production Functionality.] gorodenkoff Novartis (NVS [https://seekingalpha.com/sy... Full story

Yahoo Finance • 4 days ago

Competition Bureau expands its investigation into BWX Technologies' acquisition of Kinectrics

Bureau obtains court orders from more market participants GATINEAU, QC, Nov. 19, 2025 /CNW/ - As part its ongoing investigation into BWX Technologies' acquisition of Kinectrics, the Competition Bureau has obtained court orders to gather i... Full story

Yahoo Finance • 4 days ago

Novartis announces plans to build flagship manufacturing hub in North Carolina

Novartis Pharma AG Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing of medicines across company’s main therapeutic areas in one geograp... Full story

Yahoo Finance • 4 days ago

Soft Tissue Sarcoma Market Analysis Report 2025-2035, Profiles of Novartis, Nanobiotix, Adaptimmune, and Ipsen Pharma

Company Logo The global soft tissue sarcoma market is poised for substantial growth from 2024 to 2035, driven by the rising prevalence of this rare, aggressive cancer affecting connective tissues. Key growth factors include advancements i... Full story

Yahoo Finance • 4 days ago

Inherited Retinal Disease Market Analysis Report 2025-2035, Featuring Profiles of Novartis, GenSight Biologics, Aldeyra Therapeutics, and Spark Therapeutics

Company Logo The global inherited retinal disease market is poised for significant growth by 2025, driven by increasing prevalence of retinal conditions and advancements in genetic and cell-based therapies. Key diseases include retinitis... Full story

Yahoo Finance • 4 days ago

Portal Hypertension Drugs Market Research Report 2025-2035: Key Dynamics, Pipeline Analysis, Regulatory Landscape, Epidemiology

Company Logo The global portal hypertension drugs market is thriving due to rising liver disease rates, particularly cirrhosis and hepatitis, and an aging global population, leading to heightened demand for effective therapies. Key player... Full story

Yahoo Finance • 5 days ago

Consumer Healthcare Market Size to Surpass USD 588.68 Billion by 2032 Fueled by Rising Self Care Trends and Strong Growth of Digital Health Platforms – SNS Insider

Austin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Consumer Healthcare Market Size and Growth Outlook According to SNS Insider, the global Consumer Healthcare Market reached USD 302.87 billion in 2023 and is projected to surpass USD 588.68 billi... Full story

Yahoo Finance • 5 days ago

Japan Contraceptives Drugs Analysis Report 2025: A $1+ Billion Market by 2030 - Technological Advancements in Drug Delivery and Digital Integration Further Propel Expansion

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Japan Contraceptives Drugs Market by Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The Japan Contraceptives Drugs... Full story

Yahoo Finance • 5 days ago

FDA inspection reveals critical supply chain vulnerabilities

When US Food and Drug Administration (FDA) inspectors arrived unannounced at Hetero Labs' warehouse facility in Visakhapatnam, India, on 19 September , they documented conditions that would result in a scathing six-observation Form 483: bi... Full story

Yahoo Finance • 5 days ago

Merck, Bristol announce additional layoffs in New Jersey

[Layoff notice after spread of Covid-19 (corona virus), Crisis of the business recession during the Covid-19 outbreak.] Tarathip Kwankeeree * Merck (MRK [https://seekingalpha.com/symbol/MRK]) and Bristol Myers Squibb (BMY [https://seeki... Full story

Yahoo Finance • 5 days ago

Microscopic Polyangiitis Market Research Report 2025-2035, Competitive Analysis of Roche, Amgen, Teva, Novartis, Baxter, Amerigen Pharma, InflaRx, Biogen, Pfizer, Celltrion

Company Logo The Global Microscopic Polyangiitis (MPA) market is experiencing growth driven by the adoption of biologic therapies, which offer targeted mechanisms and improved relapse prevention. MPA, a rare ANCA-associated vasculitis, af... Full story

Yahoo Finance • 10 days ago

Cold Agglutinin Disease (CAD) Market Analysis, Business Prospects, Case Studies and Competitive Intelligence 2025-2035

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Cold Agglutinin Disease Market - A Global and Regional Analysis: Focus on Drug Class, Dosage Form, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's... Full story

Yahoo Finance • 11 days ago

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

Novartis Pharma AG Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate of 97.4% based on... Full story

Yahoo Finance • 13 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks rose late Monday afternoon with the NYSE Health Care Index adding 0.8% and the He PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 13 days ago

Novartis launches new manufacturing facility in California

[Inside Bright Advanced Semiconductor Production Fab Cleanroom with Working Overhead Wafer Transfer System] SweetBunFactory Novartis (NVS [https://seekingalpha.com/symbol/NVS]) said on Monday that it has opened a new manufacturing facilit... Full story

Yahoo Finance • 13 days ago

Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan

Novartis Pharma AG Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients a... Full story